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1607-551X/Copyright ª 2015, KaohsiuAbstract Laparoscopic treatment of large adrenal tumors is still questionable due to concern
over the risk of malignancy as well as the technical difficulties. No exact dimensional cut-off
has been described for laparoscopic adrenalectomy (LA). In this study, we reviewed our expe-
rience with LA for masses  8 cm and tried to determine the limitations of this surgery in this
group of patients. Sixteen patients with adrenal mass  8 cm (Group 1) and 19 patients with
adrenal mass < 8 cm (Group 2) treated with transabdominal LA were included in this study.
We analyzed operative time, intraoperative and postoperative complications and length of
postoperative hospital stay with respect to tumor size and clinopathologic features. Mean
maximum tumor diameters were 91.7 mm (range, 80e150 mm) and 52.4 mm (range, 35
e73 mm) in Group 1 and Group 2, respectively. Operation time and blood loss were higher
in Group 1 compared to Group 2, but these differences did not reach significant levels
(p> 0.05). Conversion to an open procedure required in two patients, one from each group,
because of the firm attachments of adrenal mass to the surrounding tissue. In conclusion,
our study demonstrated that LA is a safe and feasible procedure for large lesions even up to
15 cm. The risk of finding incidental adrenal cortical cancer was significantly increased for
large lesions in our series as in the literature; therefore, it is important to follow the strict
oncological principles in these cases.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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The first laparoscopic adrenalectomy (LA) was performed
by Gagner et al. [1] in 1992, in a case of Cushing’s syn-
drome. Since then, LA has become the procedure of choice
for most adrenal pathologies. The superiority of LA over
open procedures, in terms of operative and perioperative
outcomes, has been proven by many investigators [2e4].
Today LA is indicated in various adrenal pathologies
including nonfunctional adenoma, pheochromocytoma,
Cushing’s disease, aldosteronoma, myelolipoma, and cyst.
The only specific contraindication for this surgery is radio-
logic evidence of invasion of the tumor to the periadrenal
tissue [5]. Laparoscopic treatment of large tumors is still
questionable due to concern over the risk of malignancy as
well as the technical difficulties. No exact dimensional cut-
off has been described for LA. Traditionally, a tumor size of
6 cm and later 8 cm has been considered as an upper limit
for LA [6,7]. In this study, we reviewed our experience with
LA for masses  8 cm and tried to determine the limitations
of this surgery in this group of patients.Methods
Between July 2005 and December 2013, 84 patients with
adrenal masses underwent LA in our clinic. All patients
were evaluated with computed tomography; magnetic
resonance imaging was used in selected cases. All patients
underwent a detailed physical examination and medical
history. The laboratory investigations included routine
blood counts together with complete endocrine evaluation
to assess functioning of the adrenal mass. Indications for
surgery were hormone secreting tumors, all tumors  5 cm,
and tumor growth on follow-up. The cases that showed
suspicion of local invasion at imaging studies were accepted
as ineligible for LA. All operations were performed at a
tertiary care center by an experienced laparoscopic sur-
geon (M.A). Institutional Review Board approval was ob-
tained from the Local Ethics Committee (Izmir Bozyaka
Training and Research Hospital, Izmir, Turkey): Decision
number 1; September 08, 2015.
In 16 patients, the tumor size was measured at  8 cm
(Group 1). Transabdominal LA was performed in all patients
in Group 1. Group 2 was defined as the patients with a
maximum diameter of the tumor < 8 cm operated on
transabdominal LA (nZ 19). To homogenize the two
groups, the patients who underwent retroperitonoscopic LA
and single site surgery (all had tumor < 8 cm) were
excluded from the study. All intraoperative and post-
operative parameters were gathered from the daily prog-
ress notes and electronic records of the patients.
Postoperative complications were graded using the Clav-
ieneDindo classification scale. We analyzed operative time,
intraoperative and postoperative complications, and length
of postoperative hospital stay with respect to tumor size
and clinopathologic features. Also, the outcomes of the
procedure in large adrenal masses were evaluated accord-
ing to the tumor lateralization.Surgical technique
All laparoscopic adrenalectomies were performed through
a lateral decubitus transperitoneal approach. On the left
side, three ports (5e12 mm) were used, and an additional
fourth port was required for liver retraction on the right.
For right adrenalectomy, the liver was mobilized by dis-
secting the retroperitoneal attachments. Later, retro-
peritoneum was opened longitudinally until the vena cava
was exposed. Periadrenal fat was dissected and adrenal
vein was identified. After controlling of adrenal vein, the
inferior and superior adrenal vessels were cauterized or
clipped. The harmonic dissector was used for division of
small vessels coursing from the gland. In cases with
excessively large adrenal veins and firm attachments
around the adrenal vein, endovascular stapler was used for
vessel control. Specimens were placed into a bag and
extracted through the extension of the incision of the port
side. For left adrenalectomy, left colonic flexura was
mobilized to expose the upper pole of the kidney. The
splenic attachments were cauterized and divided until the
tail of the pancreas was exposed. Later, Gerota’s fascia was
opened and adrenal vein control and specimen extraction
was performed as described above.Results
The intra- and postoperative parameters of both groups are
summarized in Table 1. Of 84 adrenal masses, 16 were 
8 cm in diameter and three were larger than 10 cm. The
largest tumor resected laparoscopically was measured
130 cm  110 cm  150 cm. All operations were performed
via transabdominal route. Mean maximum tumor diameters
were 91.7 mm (range, 80e150 mm) and 52.4 mm (range,
35e73 mm) in Groups 1 and 2, respectively. Mean operative
time was longer in Group 1 compared to Group 2, but this
difference did not reach significance (113.4  41.0 minutes
vs. 103.2  20.2 minutes, pZ 0.765). Also, mean blood loss
was higher in Group 1 although this was not statistically
significant (141.9  80.5 mL vs. 100.5  40.1 mL,
pZ 0.143). Adrenal cortical carcinoma was found more
frequently in Group 1, whereas adrenal metastasis was
more common in Group 2. The final histopathological
diagnoses of the specimen in both groups are shown in
Table 2.
Conversion to an open procedure was required in two
patients, one from each group, because of the firm at-
tachments of adrenal mass to the surrounding tissue. The
pathological analysis of the mass that was 8 cm in diameter
revealed adrenal cortical carcinoma. The other one was
6 cm in diameter and pathology reported as adrenal ade-
noma. Splenic capsular injury occurred in three patients (2
in Group 1 and 1 in Group 2). A liver capsular laceration was
detected in another patient in Group 1. Bleeding was
controlled with electrocautery in all patients but one.
Laparoscopic splenectomy was required for a patient whose
bleeding could not be controlled with cauterization. Com-
plications are summarized in Table 3. Three patients with
Table 1 Demographical data and perioperative characteristics of two groups.
Characteristics Tumors  8 cm (n Z 16) Tumors < 8 cm (n Z 19) p
Female/male 12/4 9/10 d






Age (y) 55.2  8.6 50.1  11.4 0.239
Body mass index (kg/m2) 25.3  3.5 26.1  3.2 0.388
Tumor diameter (mm) 91.7  18.6 52.4  10.3 <0.001*
Operation time (min) 113.4  41.0 103.2  20.2 0.765
Hospitalization time (d) 2  0.8 2.3  0.6 0.146
Blood loss (mL) 141.9  80.5 100.5  40.1 0.143
Urine VMA (mg) 5.8  3.2 7.3  5.9 0.655
Urine normetanephrine (mg) 222.5  159.9 196.1  129.1 0.716
Urine epinephrine (mg) 11.1  5.2 13.4  18.3 0.487
Serum cortisol (mg/dL) 17.1  10.5 12.5  7.2 0.159
Serum aldosterone (mg) 511.4  1465.9 98.8  66.2 0.655
Serum ACTH (pmol/L) 52.2  29.4 47.9  716 0.716
Data are presented as n or mean  standard deviation.
*p < 0.05.
ACTH Z adrenocorticotropic hormone; ASA Z American Society of Anesthesiologists; VMA Z vanillyl mandelic acid.
Table 2 Final histopathological analysis of the specimen.










Table 3 Intraoperative and postoperative complications.




Liver capsule laceration 1 d
Splenic capsule laceration 2 1
Conversion to open procedure 1 1
Adrenal vein avulsion d 1
Postoperative complicationsa
Grade 1
Wound infection 2 1
Grade 2
Urinary tract infection 2 2
Blood transfusion 5 3
Grade 3A d d
Grade 3B d d
Grade 4 d d
Grade 5 d d
a According to modified Clavien classification system.
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metastatic disease on follow-up. At a mean follow-up of 22
months (range, 7e46 months), the patients with malignant
lesions experienced neither intraperitoneal recurrence nor
trocar side seeding. No statistically significant difference
was found between right sided tumors and left sided tumors
in Group 1 according to operative time and blood loss
(Table 4).
Discussion
Laparoscopic adrenalectomy has gained widespread popu-
larity since it was first described in 1992 [1]. LA provides
lower perioperative morbidity, shorter hospital stay,
decreased analgesic requirement, smaller wound, and
reduced intraoperative blood loss [3,4,8]. However, it re-
mains a challenging operation for large adrenal masses. It is
known that the risk of malignancy increases with the size of
the tumor [9]. Because of the technical difficulties, most
surgeons worry about the incomplete resection and local
recurrence due to possible capsular rupture and do not
attempt LA for large adrenal masses. However, some au-
thors reported successful management of large adrenal
tumors laparoscopically, even above 10 cm [10e13].Table 4 Outcomes according to tumor laterization.
Tumor localization Left Right p
Tumor diameter (mm) 91.0  13.5 92.4  23.7 0.712
Operation time (min) 130.0  51.4 96.9  17.9 0.269
Blood loss (mL) 163.8  101.4 120.0  50.1 0.524
Data are presented as mean  standard deviation.
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had undergone LA (15 transperitoneal LA, 7 retroperitoneal
LA) for adrenal mass  5 cm in diameter. The authors
concluded that the size of the mass on preoperative im-
aging studies alone should not be the primary factor for
performing LA. Parnaby et al. [6] compared the outcomes
of LA for adrenal tumors  6 cm with those < 6 cm in 101
patients. They reported that the outcomes of LA for adre-
nal tumors  6 cm were comparable to those with tumors <
6 cm in the absence of local invasion. Zografos et al. [7]
evaluated the outcomes of LA for adrenal tumors  8 cm
in 15 patients. They found the laparoscopic resection of
large ( 8 cm) adrenal tumors to be feasible and safe, the
outcomes did not differ according to tumor size in short and
long term. Although some authors have reported that the
adrenal masses > 7 cm can be successfully managed by
retroperitoneal LA [15], we do not prefer the retro-
peritoneoscopic approach for adrenal tumors larger than
8 cm, because limited space and technical difficulties may
increase complication rates in the retroperitoneal approach
of large adrenal masses.
Adrenal cortical carcinomas are rare tumors and lapa-
roscopic treatment of these carcinomas is still under
debate. Some authors have reported recurrent disease
after treatment of adrenal carcinoma laparoscopically
[16,17]. In the absence of local invasion, it is hard to di-
agnose adrenal cancers with imaging modalities preopera-
tively [18]. Although the size of adrenal tumor may be
correlated with the risk of malignancy, the small diameter
does not guarantee the benign behavior, because as many
as 13.5% of the resected adrenal cortical carcinomas are <
5 cm in diameter [19]. Besides size, radiological features
such as irregular margins or tumor heterogeneity were
found to be poor predictors of adrenal malignancy [18].
Furthermore, preoperative fine-needle aspiration cytology
for the evaluation of suspected malignant adrenal tumors is
unreliable [20]. Therefore imaging characteristics except
local invasion did not prevent us performing LA. Kebebew
et al. [20] evaluated the outcomes of 20 LA performed for
suspected and unsuspected malignant adrenal tumors.
Negative tumor margins were achieved in all cases. They
reported a 65% rate of overall disease-free survival at a
mean follow-up of 3.3 years and 60% rate of locoregional
recurrence that were similar to the reported open adre-
nalectomy rates. Heniford et al. [21] reported a successful
LA in 11 of 12 adrenal cortical cancers. One patient
switched to an open procedure due to local vascular tumor
invasion. On 9-month follow-up, none of the patients had
local recurrence or port-site metastasis. In our series, seven
adrenal cortical carcinomas were detected and five of them
were  8 cm in diameter. Conversion to an open procedure
was required in only one patient because of local invasion.
On follow-up, intraperitoneal recurrence or trocar site
seeding was not detected in any of the patients.
The adrenal gland is also a site of metastatic spread for
many tumors because of its rich blood supply. Adrenal
metastases tend to be smaller and often do not invade the
adrenal gland capsule unlike primary adrenal carcinomas;
thus, these tumors are more suitable for laparoscopic
resection [20]. In the present study, the biggest adrenal
metastasis was 87 mm in diameter and successfully
removed with clear resection margins.Laparoscopic adrenalectomy was also found to be
feasible in giant adrenal masses. Maestroni et al. [12] re-
ported a case of giant adrenal myelolipoma
(15 cm  12 cm  7 cm) that was managed laparoscopically.
Abraham et al. [22] reported a case of an adrenal ganglio-
neuroma measuring 17 cm  11 cm  7.5 cm that was
removed successfully by the laparoscopic approach. In our
study, the largest tumor resected laparoscopically
measured 150 mm  130 mm  110 mm and the pathology
revealed myelolipoma.
Porpiglia et al. [23] reported that only the operation
time was significantly correlated with tumor size. In our
study, operation time was longer in larger adrenal tumors
although this was not statistically significant (p> 0.05). The
increase in operative time can be explained by more
attention being paid for larger tumors, since bigger tumors
have a larger surface to be dissected and have richer
vascularization that requires more care. Operative time
tended to be greater for right-sided large masses. This may
be attributed to relatively difficult control of adrenal vein
and need to retract liver. We used endo-GIA (U.S. Surgical,
Norwalk, CT, USA) stapler in three cases with tumor size >
10 cm to control the vessels of the adrenal gland via en bloc
stapling. In these cases, the vasculature of the tumor was
very complex and it was hard to perform individual vessel
dissection. The decision was made intraoperatively, and
thereby the amount of blood loss and operation time
decreased significantly.
Novitsky et al. [13] evaluated the outcomes of LA for
large ( 5 cm) adrenal masses in 24 consecutive patients.
The authors concluded that the outcomes of right and left
adrenalectomies were similar in the case of average oper-
ating time, intraoperative blood loss, return of bowel
function, and length of hospital stay. Only the time to oral
analgesia was lower in left adrenalectomy cases. In the
present study, our findings were consistent with the previ-
ous study with regard to mean operation time and blood
loss.
The present study is a retrospective study and has some
limitations. The first comes from its retrospective design.
The retroperitoneal approach was preferred for most of the
small adrenal masses in our clinic and this may lead to a
selection bias for small masses.
In the present study, no significant correlation was
observed between the evaluated parameters and size of
the adrenal mass. Therefore, we conclude that laparo-
scopic adrenalectomy is a safe and feasible procedure for
large lesions even up to 15 cm. The risk of finding incidental
adrenal cortical cancer was significantly increased for large
masses in our series similar with the literature. It is
important to follow the strict oncological principles in
these cases.
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